A
B
C
D
E
F
G
H
I
K
L
M
N
O
P
Q
R
S
T
U
V
W

Kyowa Hakko

Company-logo  COMPANY DETAILS
Kyowa Hakko
Am Wehrhahn 50
Düsseldorf
40211
Germany
Website
Mail
Call

+49 211 175 450




HEALTH CATEGORIES

brain/mood health; eye health; general health and wellness; immune health; medical nutrition; nutraceuticals


Linkedin   
Twitter   

Kyowa Hakko is an international health ingredients manufacturer and world leader in the development, manufacturing, and marketing of pharmaceuticals, nutraceuticals, and food products. Drawing on its expertise in biotechnology and fermentation, Kyowa produces award-winning branded ingredients such as Cognizin® Citicoline, postbiotics IMMUSE® and EYEMUSE®, Setria® Glutathione and has a strong emphasis on research, science, and innovation.

Products / Markets

 Click to Enlarge








Our ingredients bear the Kyowa Quality mark, which means that all products are manufactured to meet highest quality assurance standards, supplying quality and trusted materials for various industries such as pharmaceuticals, foods, and cosmetics.


Key branded ingredients include:

IMMUSE®Lactococcus lactis strain Plasma

IMMUSE® is the first lactic acid bacteria that has been clinically researched to directly activate pDCs, a rare subset of immune cells, to provide comprehensive innate and adaptive immune support. It is a well-studied ingredient supported by 30 published studies, 15 human trials and 13 clinical efficacy studies.








Cognizin® Citicoline

Cognizin® Citicoline is a proprietary brain-health nutrient that has been clinically shown to support mental energy, focus, attention and recall. Cognizin® is approved as Novel Food Ingredient in the European Union and can be added to food supplements and food for special medical purposes.





EYEMUSE®Lacticaseibacillus paracasei
EYEMUSE® is a heat-treated probiotic (postbiotic) ofLacticaseibacillus paracasei KW3110 that has shown to combat visual fatigue and promote optimal eye health.                                                                                                                                                                                                                                                                                                                                                                                                                            








Setria® Glutathione

Known as ‘The Master Antioxidant’, Setria® Glutathione is a tripeptide composed of L-Glutamic acid, L-Cysteine and Glycine.  Setria® helps protect cells from the damaging effects of toxins and oxidative stress and plays a key role in supporting immune function. 


Setria® Performance Blend

Setria® Performance Blend is a clinically researched blend of glutathione and made in the USA L-Citrulline that may support nitric oxide production. New research in resistance-trained males suggests that  Setria® Performance Blend may help sustain NO levels which could lead to reduced fatigue and speed post-workout recovery. 


VELOX Patented Performance Blend

VELOX Blend is a clinically studied blend of two made in the USA amino acids—L-Citrulline and L-Arginine— that has been shown to boost Nitric Oxide levels more rapidly than L-Arginine alone. Help your customers achieve their personal best with VELOX Patented Performance Blend .




Articles On Nutrition Insight
MetLife stadium with the NY Jets footbal field at night with a US falg in the middle..

BUSINESS NEWS

Beyond The Headlines: Balchem teams up with the Jets, Kemin gets EC approval for pet food additive

03 May 2024 --- This week in nutrition news, Balchem Human Nutrition and Health joined forces with the NY Jets football team to promote VitaCholine. At the same time, Kemin Industries revealed it... Read More

A graphic with supplement capsules and a scientist that reads March in review.

NUTRITION & HEALTH NEWS

March in review: Balchem joins forces with Virginia Tech, Women’s History Month and NPEW 2024

01 Apr 2024 --- The major health and nutrition industry news in March included Balchem revealing a collaboration with Virginia Tech to research the health benefits of minerals, dsm-firmenich... Read More

Natural Products Expo West 2024

NUTRITION & HEALTH NEWS

NPEW 2024: Spotlight on innovations in brain, mood and mental health

18 Mar 2024 --- At this year’s Natural Products Expo West (NPEW) in California, US, mood and brain health emerged as one of the key trends, with brands presenting their scientifically backed... Read More

A pair of glasses filtering out the blue light of a screen.

NUTRITION & HEALTH NEWS

Eye health in focus: Nutritional innovations combat digital and age-related vision problems

01 Feb 2024 --- As people’s screen time increases and age-related eye concerns rise, the demand for offerings that help maintain eye health continues to expand. Nutritional supplements and... Read More

Girl drinks glass of milk.

NUTRITION & HEALTH NEWS

Beyond infant formula: Industry predicts HMO growth in gut health and immunity

25 Jan 2024 --- Human milk oligosaccharides (HMOs) — found naturally in human breast milk — are increasingly common in infant dairy formulations looking to offer nutritional benefits... Read More




Videos
FormattedPicture

FiE: Kyowa Hakko unveils its latest HMO innovations

19 Jan 2024 --- At FiE 2023, in Frankfurt, Germany, we sat down with Keiji Iga, the senior manager and head of business development Europe at Kyowa Hakko, to discuss its venture in human milk oligosaccharides (HMOs) production. He details the health benefits and versatility of 6’-Sialyllactose sodium salt and gives insights into the results of Kyowa Hakko’s recent novel food applications for 2’-Fucosyllactose and 3’-Sialyllactose sodium salt. We also explore the company’s plans for 2024.

FormattedPicture

Kyowa Hakko Bio spotlights HMOs’ potential in Chinese and Thai markets

26 Jan 2021 --- In light of the increasing global demand for HMOs, Kyowa Hakko Bio is eyeing opportunities within the Chinese and Thai markets, despite a hazy regulatory environment. Moreover, the company is investing in a new Thai facility to expand its production capacity. Kentaro Yanashima, Research & Business Development for Kyowa Hakko Bio, tells NutritionInsight all about the promising potential of HMO’s for both infant and adult nutrition and the company’s expansion plans.




Technical Papers
FormattedPicture

Activate your immune system with IMMUSE®

17 Oct 2022 --- IMMUSE® Lactococcus lactis strain Plasma is a unique, patent-protected, heat-killed lactic acid bacteria strain, more commonly referred to as a postbiotic, with a novel mechanism of action that stimulates immune function at the cellular level.This Technical Paper is from Kyowa Hakko.




Podcasts
FormattedPicture

NewsBite Podcast (Jul 19-23): “Pandemic stress causes ‘alarming’ use of supplements, reveals survey”

26 Jul 2021 --- This week’s NewsBite podcast details how COVID-19 has had a major impact on consumer habits around supplementation, with NPD tackling everything from weight management to immunity. Additionally, Kappa Bioscience investigated the link between COVID-19 outcomes and levels of vitamins D and K2.




A
B
C
D
E
F
G
H
I
K
L
M
N
O
P
Q
R
S
T
U
V
W